Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Not yet recruiting 2Completed 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 11Recurrence 5Lymphoma, B-Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm Metastasis 3Lymphoma, Mantle-Cell 3Leukemia 3Hematologic Neoplasms 3Oropharyngeal Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid 2Hodgkin Disease 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Pinealoma 1

Interventions

Magnetic Resonance Spectroscopy 3fludarabine 2Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1Watchful Waiting 1Taxes 1Radiotherapy, Adjuvant 1Radiotherapy 1Radiosurgery 1Radiation 1Paclitaxel 1Observation 1Immune Checkpoint Inhibitors 1Chemoradiotherapy 1Cetuximab 1Carboplatin 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Oropharyngeal Neoplasms × fludarabine × Clear all
NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

SCG Cell Therapy Pte. Ltd.

Phase 1/2 Not yet recruiting
66 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡